 
        
        
        T16Ainh-A01是一种氨基苯噻唑类化合物,是强效的转膜蛋白16A(TMEM16A)抑制剂,能抑制TMEM16A介导的氯离子电流,IC50约为1 µM。TMEM16A(ANO1)作为钙激活的氯通道(CaCC)。
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 描述 | T16Ainh-A01, an aminophenylthiazole, is a potent transmembrane protein 16A (TMEM16A) inhibitor, inhibiting TMEM16A-mediated chloride currents with an IC50 value of ~1 µM. TMEM16A (ANO1) functions as a calcium-activated chloride channel (CaCC). Depolarization-evoked I ClCa in isolated RUICC, recorded using voltage clamp, were inhibited by T16Ainh-A01 with IC50 values of 3.4 μM. Eurogenic contractions of strips of rabbit urethra smooth muscle (RUSM), evoked by electric field stimulation (EFS), were also significantly reduced by T16Ainh-A01[1]. T16Ainh-A01 (10 μM) inhibits nearly completely TMEM16A chloride current (induced by 275 nM free calcium in the pipette) at all voltages, indicating a voltage-independent block mechanism[2]. T16Ainh-A01 led to the significant repression of cell proliferation, cell migration, and collagen secretion in CFs(cardiac fibroblasts)[3]. Suppression of ANO1 activity either by selective inhibitor (T16Ainh-A01) or by siRNA significantly attenuated the migration and invasion of ATC (Anaplastic thyroid carcinoma) cells[4]. | 
| Concentration | Treated Time | Description | References | |
| Mouse retinal rod bipolar cells | 10 µM | 200 milliseconds | Inhibited outward rectifying current, confirming the voltage-dependent component of ANO1 | Cells. 2020 Feb 26;9(3):543 | 
| SH-SY5Y cells | 10–30 µM | 24 hours | Evaluate the effect of T16Ainh-A01 on HRSV-GFP expression, results showed significant reduction in HRSV-GFP expression | Thorax. 2021 Jan;76(1):64-72 | 
| A549 cells | 5–30 µM | 24 hours | Evaluate the effect of T16Ainh-A01 on HRSV-GFP expression, results showed significant reduction in HRSV-GFP expression | Thorax. 2021 Jan;76(1):64-72 | 
| HaCaT keratinocytes | 30 µM | 3 days | Inhibition of HaCaT cell proliferation and reduction of pERK1/2 phosphorylation | Int J Mol Sci. 2021 Jul 1;22(13):7145 | 
| Vascular smooth muscle cells (VSMCs) | 10 µM | 30 minutes | Inhibiting TMEM16A activity, significantly reducing the expression of VCAM-1 and ICAM-1 | Biomedicines. 2022 Oct 31;10(11):2760 | 
| Mouse retinal rod bipolar cells | 40 µM | 300 seconds | Inhibited ANO1 tail current (I tail), indicating ANO1 is activated by Ca2+ | Cells. 2020 Feb 26;9(3):543 | 
| Mouse cardiac vascular endothelial cells (CVECs) | 30 µM | 48 hours | To evaluate the effect of T16Ainh-A01 on CVECs proliferation, results showed T16Ainh-A01 did not affect cell growth | Br J Pharmacol. 2014 Aug;171(15):3680-92 | 
| Dorsal root ganglia neurons | 20 µM and 100 µM | 90 seconds | ANO1 blockade with T16Ainh-A01 significantly inhibited the PGE2-evoked axonal depolarisation | Sci Rep. 2024 Jul 29;14(1):17360 | 
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6N mice | Cerulein-induced acute pancreatitis model | Intraperitoneal injection | 1 mg/kg | Single injection, lasting 12 hours | To investigate the effect of T16Ainh-A01 on the acute pancreatitis mouse model, results showed that T16Ainh-A01 ameliorated pancreatic damage and reduced IL-6 levels in serum and pancreatic tissues. | J Adv Res. 2020 Jan 21;23:25-35 | 
| Genetically epilepsy-prone rats (GEPR-3s) | Genetically epilepsy-prone rat model | Oral | 10 mg/kg | Single dose, tested 30 minutes after administration | To evaluate the effects of T16Ainh-A01 on acoustically evoked seizures in GEPR-3s. Results showed that T16Ainh-A01 pretreatment did not significantly alter the incidence of WRSs and GTCSs, seizure latency, seizure duration, or seizure severity. | Biomedicines. 2022 Feb 15;10(2):449 | 
| Sprague-Dawley rats | Chronic constriction injury (CCI) model | Intrathecal injection | 10 μg | Once every 6 hours, totally five times | To evaluate the effect of T16Ainh-A01 on CCI-induced neuropathic pain. Results showed that T16Ainh-A01 significantly alleviated thermal hyperalgesia, reduced the excitability of DRG neurons, and decreased TMEM16A expression. | Neural Regen Res. 2019 Jun;14(6):1091-1098 | 
| Guinea pig | Tracheal rings | Organ baths | 10 μM, 50 μM, 100 μM | 30-minute intervals | To investigate the relaxant effect of T16Ainh-A01 on acetylcholine-induced contraction. Results showed that 50 μM and 100 μM T16Ainh-A01 significantly relaxed the acetylcholine-induced contraction. | Anesthesiology. 2015 Sep;123(3):569-81 | 
| BALB/c mice | IMQ-induced psoriasis-like skin injury model | Topical application on ears | 30 µM and 100 µM | Once daily for 7 consecutive days | Alleviation of psoriasis-like symptoms and reduction of ANO1 and pERK1/2 expression | Int J Mol Sci. 2021 Jul 1;22(13):7145 | 
| Mice | Pain-related behavior model | Hind paw injection | 300 μM | Single injection, observed for 5 minutes | Investigate the effect of ANO1 antagonist T16Ainh-A01 on capsaicin-induced pain-related behaviors, finding that A01 significantly reduced capsaicin-induced pain behaviors | Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5213-8 | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 2.40mL 0.48mL 0.24mL | 12.00mL 2.40mL 1.20mL | 24.01mL 4.80mL 2.40mL | |
| CAS号 | 552309-42-9 | 
| 分子式 | C19H20N4O3S2 | 
| 分子量 | 416.52 | 
| SMILES Code | O=C(NC1=NC(C2=CC=C(OC)C=C2)=CS1)CSC3=NC(C)=C(CC)C(N3)=O | 
| MDL No. | MFCD03278952 | 
| 别名 | T16A(inh)-A01 | 
| 运输 | 蓝冰 | 
| InChI Key | QSIYTNYMBWYHAA-UHFFFAOYSA-N | 
| Pubchem ID | 135460621 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,Store in freezer, under -20°C | 
| 溶解方案 | DMSO: 85 mg/mL(204.07 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO DMF: 10 mg/mL(24.01 mM) 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1